Cargando…
PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients
This study aims to investigate the changes of cytokines and the effect of programmed death ligand 1 (PD-L1) signaling pathway on T cell function in patients with immune thrombocytopenic purpura (ITP). Totally, 40 untreated ITP patients were recruited and 30 healthy people were recruited as the healt...
Autores principales: | Wu, Die, Liu, Ying, Pang, Nannan, Sun, Mingling, Wang, Xiujuan, Haridia, Yasen, Zhao, Fang, Qin, Yuting, Fan, Wenxia, Guo, Xinhong, Ding, Jianbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824755/ https://www.ncbi.nlm.nih.gov/pubmed/31651870 http://dx.doi.org/10.1097/MD.0000000000017608 |
Ejemplares similares
-
Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura
por: Roriz, Mélanie, et al.
Publicado: (2015) -
The role of STAT3 and AhR in the differentiation of CD4(+) T cells into Th17 and Treg cells
por: Liu, Xingxing, et al.
Publicado: (2017) -
Characterization of PD-1/PD-L1 immune checkpoint expression in the pathogenesis of musculoskeletal Langerhans cell histiocytosis: A retrospective study
por: Hashimoto, Kazuhiko, et al.
Publicado: (2021) -
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
por: Emmi, Giacomo, et al.
Publicado: (2016) -
Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis
por: Sun, Xiaoying, et al.
Publicado: (2017)